Novel GPCR screening approach: indirect identification of S1P receptor agonists in antagonist screening using a

Sandra Siehler1, Danilo Guerini

  • 1Discovery Technologies, Novartis Institutes for BioMedical Research, Basel, Switzerland. sandra.siehler@novartis.com